GMC-252

N/A

Report date: 2026/02/28 20:00:37

Base Information

Drug NameGMC-252
Drug Alias NameGMC-252GMC-252-L-lysine salt
ClassificationSmall molecules
Mechanisms of ActionInflammation mediators inhibitors
TargetsInflammation mediators
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenmedica Therapeutics Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenmedica Therapeutics Sl
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A